Replies to post #54880 on Biotech Values

[ThomasS]

MNTA: The collaboration will include one late-stage compound from Momenta's pipeline and two late-stage compounds from Sandoz.

The collaboration also expands the companies' existing U.S. partnership on M-Enoxaparin, which was established in November 2003, to the European Union.

--- I am still at a loss to understand where this stands in development in regards to EU. (M-Enox)